Paper126557
Biological properties of the peptidoglycan.
Heymer B. Z Immunitatsforsch Exp Klin Immunol, 1975. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Biological properties of the peptidoglycan. Papers, record 126557. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/126557
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Peptidoglycan | Major topic |
| Adjuvants, Immunologic | |
| Animals | |
| Antibodies, Bacterial | |
| Bacillus megaterium | |
| Cell Migration Inhibition | |
| Chemotaxis | |
| Inflammation | |
| Muramidase | |
| Necrosis | |
| Neutralization Tests | |
| Phagocytosis | |
| Skin Manifestations | |
| Staphylococcal Infections | |
| Staphylococcus | |
| Streptococcus | |
| Virulence |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7523297 | Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. | Infect Immun | 1994 | https://conductscience.org/library/papers/7523297 | PubMed |
| 7439988 | Modulation of mitogenic responsiveness by staphylococcal peptidoglycan. | Infect Immun | 1980 | https://conductscience.org/library/papers/7439988 | PubMed |
| 7287182 | Antibody levels to bacterial peptidoglycan in human sera during the time course of endocarditis and bacteremic infections caused by Staphylococcus aureus. | Infect Immun | 1981 | https://conductscience.org/library/papers/7287182 | PubMed |
| 6884337 | Lysis and biodegradation of microorganisms in infectious sites may involve cooperation between leukocyte, serum factors and bacterial wall autolysins: a working hypothesis. | Eur J Clin Microbiol | 1983 | https://conductscience.org/library/papers/6884337 | PubMed |
| 6799403 | Complement consumption gonococcal peptidoglycan. | Infect Immun | 1982 | https://conductscience.org/library/papers/6799403 | PubMed |
| 6690400 | Detection of soluble peptidoglycan in urine after penicillin administration. | Infect Immun | 1984 | https://conductscience.org/library/papers/6690400 | PubMed |
| 6605928 | Soluble peptidoglycan from Staphylococcus aureus is a murine B-lymphocyte mitogen. | Infect Immun | 1983 | https://conductscience.org/library/papers/6605928 | PubMed |
| 3875561 | Soluble non-cross-linked peptidoglycan polymers stimulate monocyte-macrophage inflammatory functions. | Infect Immun | 1985 | https://conductscience.org/library/papers/3875561 | PubMed |
| 3720793 | Changes of pharmacokinetics of trimethoprim after pretreatment with streptococcal peptidoglycan. | Eur J Drug Metab Pharmacokinet | 1986 | https://conductscience.org/library/papers/3720793 | PubMed |
| 2437150 | Antibodies to various bacterial cell wall peptidoglycans in human and rabbit sera. | J Clin Microbiol | 1987 | https://conductscience.org/library/papers/2437150 | PubMed |
| 313370 | Mitogenic activity of staphylococcal peptidoglycan. | Infect Immun | 1979 | https://conductscience.org/library/papers/313370 | PubMed |
| 92461 | Rheumatoid arthritis: review of searches for an infectious cause. Part II. | Infection | 1979 | https://conductscience.org/library/papers/92461 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/126557
GET https://conductscience.org/api/papers/v1/126557/authors